Skip to main content
OpenTrials

Clinical trial condition

Herpes Genitalis

Explore clinical trials studying Herpes Genitalis. Study availability and eligibility vary by location and protocol.

12 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Herpes Genitalis trial results

Completed

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

NCT04950712

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +13 more
Locations
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Miami, Florida, United States
View all 51 locations
View Trial Details
Completed

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

NCT02837575

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +17 more
Locations
  • Alabama Vaccine Research Clinic at University of Alabama at Birmingham Birmingham, Alabama, United States
  • Medical Center for Clinical Research San Diego, California, United States
  • QPS Broward Research Hollywood, Florida, United States
  • QPS Miami Research Associates South Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

NCT00158860

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +13 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Anaheim, California, United States
View all 72 locations
View Trial Details

Related conditions